Finance

Lists
Outlook: 38.5% bullish·0.0% bearish
Go to analysis
WELL:NYSE
Welltower Inc
$233.51
-0.57%
(-1.34) 1D
$233.51
0.00% (0.00)
After hours
Closed: Oct 19, 4:02:31 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for WELL...
Open
$233.46
High
$235.55
Low
$230.00
Mkt. cap
168.30B
Avg. vol.
2.62M
Volume
1.91M
Dividend
1.31%
Quarterly dividend
$0.77
Ex-dividend date
Aug 12, 2026
P/E ratio
106.49
52-wk high
$255.20
52-wk low
$173.12
EPS
$2.19
Beta
0.75
Shares outstanding
720.74M
No. of employees
712
Open
$233.46
High
$235.55
Low
$230.00
Mkt. cap
168.30B
Avg. vol.
2.62M
Volume
1.91M
Dividend
1.31%
Quarterly dividend
$0.77
Ex-dividend date
Aug 12, 2026
P/E ratio
106.49
52-wk high
$255.20
52-wk low
$173.12
EPS
$2.19
Beta
0.75
Shares outstanding
720.74M
No. of employees
712
News stories
From web sources and news partners
Profile
Welltower Inc. is an American real estate investment trust that invests in healthcare facilities such as retirement and nursing homes, and outpatient medical clinics. As of December 31, 2022, the company had investments in approximately 3,000 properties, all of which were in the United States, Canada, and the United Kingdom. The company’s stock is listed in the S&P 500. Wikipedia
About Welltower Inc
CEOShankh Mitra
Employees712
Founded1970
HeadquartersToledo, Ohio, United States
SectorReal estate investment trust
Websitewelltower.com
Analyst ratings
Based on 16 analysts giving stock ratings to WELL in the past 3 months
Strong buy
Buy
15
Hold
1
Sell
0
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for WELL in the last 3 months.
Highest
Current $233.51
$275.00 (+17.77%)
Average
$245.13 (+4.98%)
Lowest
$6.02 (-97.42%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Kilichowski
Wells Fargo
Buy
Reiterated
$268.00
+14.8%
10/19/2026
Michael Goldsmith
UBS
Buy
Maintained
$269.00
+15.2%
10/13/2026
Richard Hightower
Barclays
Hold
Maintained
$246.00
+5.3%
10/13/2026
Farrell Granath
Bank of America Securities
Buy
Maintained
-
-
10/12/2026
Juan C. Sanabria
BMO Capital
Buy
Reiterated
$265.00
+13.5%
10/02/2026
Michael Mueller
J.P. Morgan
Buy
Upgraded
$260.00
+11.3%
09/24/2026
James Kammert
Evercore ISI
Buy
Maintained
$256.00
+9.6%
09/21/2026
Joe Dickstein
Jefferies
Buy
Initiated
$275.00
+17.8%
09/15/2026
Nicholas Yulico
Scotiabank
Buy
Maintained
$251.00
+7.5%
09/02/2026
Ronald Kamdem
Morgan Stanley
Buy
Maintained
$251.00
+7.5%
09/02/2026
Justin Keywood
Stifel Nicolaus
Buy
Maintained
CA$8.50
-96.4%
08/05/2026
Austin Wurschmidt
KeyBanc
Buy
Maintained
$275.00
+17.8%
08/04/2026
Richard Anderson
Cantor Fitzgerald
Buy
Reiterated
$260.00
+11.3%
07/31/2026
Nicholas Joseph
Citi
Buy
Maintained
$275.00
+17.8%
07/31/2026
Michael Carroll
RBC Capital
Buy
Maintained
$260.00
+11.3%
07/31/2026
Vikram Malhotra
Mizuho Securities
Buy
Maintained
$260.00
+11.3%
07/22/2026
Unknown Analyst
Wells Fargo
Buy
Reiterated
$268.00
+14.8%
07/15/2026
Unknown Analyst
Raymond James
Buy
Initiated
$226.00
-3.2%
06/16/2026
Dave Rodgers
Raymond James
Buy
Initiated
$226.00
-3.2%
06/16/2026
Jonathan Petersen
Jefferies
Buy
Maintained
$248.00
+6.2%
05/12/2026
Andy Barish
Jefferies
Buy
Maintained
$375.00
+60.6%
04/13/2026
Next call in 8 days
Tue, Oct 27, 3:00 PM
Fiscal period
Q3 2026
- / $0.62
Revenue / Est. (USD)
- / 3.75B
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.69B
3.18B
3.35B
3.54B
Cost of goods sold
1.58B
1.93B
2.06B
2.15B
Cost of revenue
1.58B
1.93B
2.06B
2.15B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
63.12M
1.56B
67.47M
67.49M
Operating expense
572.94M
2.15B
690.23M
805.25M
Total operating expenses
2.15B
4.08B
2.75B
2.96B
Operating income
534.62M
-897.07M
604.65M
587.03M
Other non operating income
-76.38M
-120.19M
-61.14M
-56.93M
EBT including unusual items
284.52M
112.78M
763.96M
401.00M
EBT excluding unusual items
283.58M
-1.22B
349.11M
330.22M
Income tax expense
2.34M
-4.98M
11.63M
-61.98M
Effective tax rate
0.82%
-4.42%
1.52%
-15.46%
Other operating expenses
-
-
-
-
Net income
280.56M
96.44M
728.67M
445.00M
Net profit margin
10.45%
3.03%
21.74%
12.55%
Earnings per share
0.55
0.55
0.55
0.54
Interest and investment income
-
-
-
-
Interest expense
-162.05M
-203.78M
-192.72M
-181.91M
Net interest expenses
-162.05M
-203.78M
-192.72M
-181.91M
Depreciation and amortization charges
509.81M
594.15M
622.75M
737.76M
EBITDA
1.06B
-290.19M
1.24B
1.34B
Gain or loss from assets sale
-4.02M
-1.38B
-420.40M
-98.54M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps